Surface Oncology, Inc. (11)

Browse by Contract Category

Contracts

First Amendment to Loan and Security Agreement, dated October 1, 2021, by and among Surface Oncology, Inc. and, K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on October 4, 2021)
Amendment No. 1, dated as of August 5, 2021, to Capital on DemandTM Sales Agreement, dated as of May 22, 2020, by and between Surface Oncology, Inc. and JonesTrading Institutional... (Filed With SEC on August 5, 2021)
Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Filed With SEC on May 5, 2021)
Amended and Restated Employment Agreement, dated April 26, 2021, by and between Jessica Fees and Surface Oncology, Inc (Filed With SEC on April 27, 2021)
Description of the Registrant's Securities (Filed With SEC on March 10, 2020)
Sublease Agreement by and between the Company and EQRx, Inc., dated December 16, 2019 (Filed With SEC on March 10, 2020)
Amended and Restated Employment Agreement, dated February 9, 2020, by and between Robert Ross, M.D. and Surface Oncology, Inc (Filed With SEC on February 11, 2021)
Transition and CEO Support Agreement, dated February 9, 2020, by and between J. Jeffrey Goater and Surface Oncology, Inc (Filed With SEC on February 11, 2021)
License Agreement, dated as of December 16, 2020, by and between the Company and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED (Filed With SEC on December 17, 2020)
Capital on DemandTM Sales Agreement, dated as of May 22, 2020, by and between the Company and JonesTrading Institutional Services LLC (Filed With SEC on May 22, 2020)
Loan and Security Agreement, dated November 22, 2019, by and among Surface Oncology, Inc. and, K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on November 25, 2019)